American Thoracic Society - Sanofi Investor Call
Age, mean (SD) — years
Baseline Demographics and Disease Characteristics
Characteristic
Dupilumab
(N = 468)
All
(N = 939)
65.1 (8.1)
Placebo
(N = 471)
65.2 (8.1)
65.0 (8.0)
Male, no. (%)
322 (68.4)
298 (63.7)
620 (66.0)
-
Race White, no. (%)
397 (84.3)
393 (84.0)
790 (84.1)
Ethnicity - Hispanic or Latino, no. (%)
129 (27.4)
132 (28.2)
261 (27.8)
Smoking status
Former smoker, no. (%)
323 (68.6)
334 (71.4)
657 (70.0)
Current smoker, no. (%)
148 (31.4)
134 (28.6)
282 (30.0)
Pack-years, mean (SD)
41.4 (24.4)
39.6 (22.3)
40.5 (23.4)
BMI, mean (SD) - kg/m²
27.6 (5.7)
27.5 (5.4)
27.6 (5.6)
Background medication
Triple therapy (ICS+LAMA+LABA), no. (%)
461 (97.9)
455 (97.2)
916 (97.6)
Inhaled corticosteroid, high dose, no. (%)
126 (26.8)
131 (28.0)
257 (27.4)
ATS 2023
23View entire presentation